Showing results (101-110 of 425) with videos related to

Sort By:
Pageof 43
Cancer Research|October 6, 2005
Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12Robin Parihar, Rossana Trotta, Julie M Roda, et al.
Blood Advances|June 3, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium studyTheresa Hahn, Qiuhong Zhao, Elizabeth Greer Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Kendra L Sweet, Anthony S Stein, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating AgentMichael Ozga, Ying Huang, James S Blachly, et al.
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
The Journal of Experimental Medicine|April 12, 2006
Evidence for discrete stages of human natural killer cell differentiation in vivoAharon G Freud, Akihiko Yokohama, Brian Becknell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Complex role of NK cells in regulation of oncolytic virus-bortezomib therapyYangjin Kim, Ji Young Yoo, Tae Jin Lee, et al.
Leukemia & Lymphoma|February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experienceFiliz Yucebay, Christina Matthews, Marcin Puto, et al.
Haematologica|January 15, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness levelNaveen Pemmaraju, Marco Herling, Kendra L Sweet, et al.
Blood|June 1, 2007
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemiaLisheng Wang, Jie Wang, Bradley W Blaser, et al.
Pageof 43